Overview of SRPK Plasmids

SRPK (Serine/Arginine-rich Protein Kinase) Plasmids are essential tools in the study of splicing regulation and cell signaling pathways. SRPKs are a family of kinases that specifically phosphorylate serine/arginine (SR)-rich proteins, which play crucial roles in both constitutive and alternative splicing of pre-mRNA. SRPKs are involved in various cellular processes, including gene expression, cell cycle progression, and stress responses.


  • SRPK Plasmids: Technical Insights
  • Structure and Function:
    • Gene: The SRPK family includes several members, such as SRPK1 and SRPK2. These genes encode kinases that specifically phosphorylate SR proteins, regulating their function in RNA splicing.
    • Protein Domains: SRPK proteins typically have a conserved kinase domain that mediates their enzymatic activity and an N-terminal domain that is involved in substrate recognition and binding.
    • Function: SRPKs regulate the localization and activity of SR proteins, influencing both constitutive and alternative splicing. By phosphorylating SR proteins, SRPKs control their ability to assemble spliceosomal complexes and modulate splicing decisions.
  • Applications:
    • Splicing Research: SRPK plasmids are used to study the regulation of splicing. Overexpression or silencing of SRPK genes helps researchers understand their role in controlling the splicing of pre-mRNA and the generation of various mRNA isoforms.
    • Cancer Studies: Aberrant splicing is a hallmark of many cancers. SRPKs have been implicated in the misregulation of splicing events in cancer cells. SRPK plasmids are employed to explore their role in tumorigenesis and to develop potential therapeutic strategies targeting SRPK-mediated splicing pathways.
    • Neurological Disorders: SRPKs are involved in the splicing of genes associated with neurological functions. SRPK plasmids can be used to investigate their role in neurodegenerative diseases and other neurological disorders.
  • Types of SRPK Plasmids:
    • Overexpression Plasmids: These plasmids contain the full-length SRPK cDNA under a strong promoter, enabling high levels of SRPK expression in transfected cells. This is useful for studying the function and regulation of SRPKs in various cellular processes.
    • shRNA/siRNA Plasmids: Designed to knock down SRPK expression, these plasmids express short hairpin RNA (shRNA) or small interfering RNA (siRNA) sequences that target SRPK mRNA for degradation, reducing its expression and allowing for the study of loss-of-function effects.
    • Reporter Plasmids: These plasmids include SRPK-responsive elements linked to a reporter gene, such as GFP or luciferase, allowing for the monitoring of SRPK activity and its effects on splicing regulation.
  • Experimental Considerations:
    • Transfection Efficiency: The effectiveness of SRPK plasmids relies on efficient delivery into target cells. Various transfection methods, including lipid-based transfection, electroporation, and viral vectors, should be optimized based on cell type and plasmid construct.
    • Controls: Proper experimental controls, such as empty vector plasmids and non-targeting shRNA plasmids, are crucial to validate the specificity and efficacy of SRPK manipulation.
    • Validation: Post-transfection, the expression and activity of SRPK should be validated using techniques such as Western blotting, qPCR, and splicing assays to confirm the intended modification.
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pEnCMV-HA-SRPK1 (human) -SV40-Neo
CAT# AFG-GNC-16507
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pCMV-SRPK1 (human) -3×Myc-Neo
CAT# AFG-GNC-13190
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pCMV-mCherry-SRPK1 (human) -Neo
CAT# AFG-GNC-11887
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
CAT# AFG-NVF-094059
Size: 2 μg
276.00 276.0 USD
AffiPLASMID® pBluescriptR-SRPK2
CAT# AFG-NVF-075262
Size: 2 μg
276.00 276.0 USD